04.03.17
Galderma’s marketing collaboration with Colorescience is aimed at individuals seeking innovative daily skin care products that can be used in conjunction with traditional facial injectable aesthetic treatments. Research shows that there are currently two million US women who regularly participate in the aesthetic injectables market, while approximately 17 million are considering aesthetic injectable treatment. Additionally, approximately 34 million US women purchase skin care products at their doctor’s office annually.
This collaboration provides a significant opportunity to leverage the overlapping markets, providing exposure to the population interested in both. It will increase access to aesthetic facial injectables and protective makeup products to more cosmetic and dermatology practices, according to the firms.
This collaboration provides a significant opportunity to leverage the overlapping markets, providing exposure to the population interested in both. It will increase access to aesthetic facial injectables and protective makeup products to more cosmetic and dermatology practices, according to the firms.
